| Old Articles: <Older 13071-13080 Newer> |
 |
The Motley Fool March 17, 2006 Tim Beyers |
Stock Madness 2006: Winning With Balance All-value and all-growth may not get you as far as a team that has a good mix of both. Chattem... Embraer... iRobot... Oracle... etc.  |
The Motley Fool March 17, 2006 Nathan Parmelee |
Stock Madness 2006: The Value Underdogs Don't underestimate this team's potential to perform. Enterprise Products Partners... Intel... Wells Fargo... 3Com... etc.  |
The Motley Fool March 17, 2006 Rex Moore |
Stock Madness 2006: Superior Staying Power Two experienced powerhouses combine with rookies ready for a fast break in this investing game. Procter & Gamble... Portfolio Recovery Associates... RF Micro Devices... etc.  |
The Motley Fool March 17, 2006 Rich Smith |
Foolish Forecast: Oracle Earnings Oracle's stock has risen 35% since hitting a low of $10 per stub back in September 2004. Yet strangely, this rise in stock price has mirrored a slide in the company's profitability.  |
The Motley Fool March 17, 2006 Rich Smith |
Foolish Forecast: Healthways Healthways' stock price may be up from last year, but it's been sagging over the last few months. One reason: margin weakness.  |
The Motley Fool March 17, 2006 Will Frankenhoff |
Rowan Set to Pump Up Profits Rowan Companies boasts a first-rate fleet of jack-up rigs, is heavily leveraged to an increase in dayrates in the tight Gulf of Mexico market, and trades at a 14% discount to its peers. What's not to like?  |
The Motley Fool March 16, 2006 Stephen D. Simpson |
ConAgra Swallows Hard An ugly next few years could lead to a brighter future. Investors, if you want to take a chance on this turnaround today -- good luck.  |
BusinessWeek March 27, 2006 Gene G. Marcial |
Hershey: A Sweeter Bid Hershey walked away from the table after it put itself on the block four years ago. Now it might be coming back.  |
BusinessWeek March 27, 2006 Gene G. Marcial |
Cortex Draws A Bead On Hyperactivity When Cortex Pharmaceuticals disclosed on Mar. 8 that its lead drug, CX717, showed favorable results in Phase 2 trials for the treatment of adult ADHD, the stock jumped.  |
BusinessWeek March 27, 2006 Gene G. Marcial |
Vodafone Has A Nice Ring To It Whatever Vodafone Group decides to do with its 45% stake in Verizon Wireless, some see the world's largest mobile carrier as a great bargain.  |
| <Older 13071-13080 Newer> Return to current articles. |